Shire Weighing Revised £44B Buyout Offer From Takeda
Dublin-based Shire said Friday it was mulling a revised £44 billion ($62 billion) takeover offer from Japan's Takeda Pharmaceuticals, just a day after the rare-disease-focused pharmaceutical company revealed it had rejected...To view the full article, register now.
Already a subscriber? Click here to view full article